Janet Woodcock still has questions about how President Biden’s health care discovery accelerator ARPA-H and the FDA will work together to bring new ideas to the health care system and patients.
Woodcock, the US Food and Drug Administration’s principal deputy commissioner, said the agency will have to work closely with the...






